Abstract 13241: The Role of Nox2-Derived Oxidative Stress in High-Fat Diet Induced Hematopoietic Stem Cell Dysfunction in Mice
Obesity related metabolic disorders are characterized by systemic oxidative stress associated with high risks of cardiovascular diseases. Bone marrow-derived hematopoietic stem cells (BMSC) hold the hope for regeneration of diseased endothelium; however, the effect of oxidative stress on BMSC function remains unknown. Recently, a superoxide producing NADPH oxidase 2 (Nox2) has been found to be involved in obesity-related oxidative stress. In this study, we investigated BMSC function in mouse models of middle-aged obesity. Age-matched littermates of C57BL/6J wild-type and Nox2 knockout mice (7 m old, n=15) were fed with high fat diet (HFD, 45% kcal fat, 20% kcal protein and 35% kcal carbohydrate) or normal chow diet (NCD, 12% kcal fat, 28% kcal protein and 60% kcal carbohydrate) for 16 weeks. BMSCs were isolated from mice at 11 months of age. Compared to NCD controls, the numbers of CD133+/VEGFR2+ endothelial progenitor cells (EPC) were significantly decreased (3.2%±0.3 NCD vs 0.8%±0.5 HFD) in HFD mice. Furthermore, there were significant increases (92±9.2%) in the levels of O2.- production by HFD BMSC, and this was accompanied with accelerated ex vivo cell proliferation (160±5.2%), cell cycle progression from G1/G0 phase to S phase, and importantly, HFD was associated with a 4-fold increase in inflammatory cell population (CD45+) examined by FACS. Isolation of CD133+ cells using magnetic beads showed a significant increase in HFD associated cell apoptosis (6.9±2.5% NCD vs 29.8±8.2% HFD) as examined by annexin V flow cytometry. Moreover, the level of p53 expression in EPC was significantly increased with HFD treatment. However, all these changes were absent in BMSC isolated from Nox2 knockout mice fed with HFD. In conclusion, an obese environment activates Nox2 and oxidative stress damages BMSC function and reduces EPC population. Nox2 may present a potential therapeutic target for the prevention and treatment of obesity-related diseases.
- © 2012 by American Heart Association, Inc.